Bide Pharmatech Co (SHSE:688073) Total Stockholders Equity : ¥2,045 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bide Pharmatech Co Total Stockholders Equity?

Bide Pharmatech Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,045 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Bide Pharmatech Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥22.50. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Bide Pharmatech Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.04.

Bide Pharmatech Co Total Stockholders Equity Historical Data

The historical data trend for Bide Pharmatech Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bide Pharmatech Co Total Stockholders Equity Chart

Bide Pharmatech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

136.20

364.26

628.86

2,076.15

2,089.54

Bide Pharmatech Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial											2,107.98	2,042.66	2,083.09	2,089.54	2,045.24

Bide Pharmatech Co (SHSE:688073) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Bide Pharmatech Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2045.24	-	0)	/	90.8829
	=	22.50

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Bide Pharmatech Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(56.799	+	32.041)	/	2045.24
	=	0.04

Bide Pharmatech Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Bide Pharmatech Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bide Pharmatech Co (SHSE:688073) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bide Pharmatech Co Ltd (SHSE:688073) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No. 128, Xiangyin Road, Room 101, Block A, Building 11, Yangpu District, Shanghai, CHN, 200433

Website

https://www.bidepharmatech.com

Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.

Bide Pharmatech Co (SHSE:688073) Headlines

No Headlines